Seasoned growth-stage investor and operating executive with experience across technology and healthcare investing, portfolio company operations, and capital raising. Chad Tobin brings a background blending corporate development, venture capital and hands-on operational leadership, often focusing on revenue scaling, go-to-market execution and M&A. Known for structuring growth equity investments and board-level oversight, works with founders and LPs to align strategic plans and exit pathways. Active in North American middle-market transactions.
Seasoned growth-stage investor and operating executive with experience across technology and healthcare investing, portfolio company operations, and capital raising. Chad Tobin brings a background blending corporate development, venture capital and hands-on operational leadership, often focusing on revenue scaling, go-to-market execution and M&A. Known for structuring growth equity investments and board-level oversight, works with founders and LPs to align strategic plans and exit pathways. Active in North American middle-market transactions.
Focuses on growth‑equity investments in North American middle‑market technology and healthcare companies, prioritizing revenue scaling, repeatable go‑to‑market models and strategic M&A to accelerate exits. Capital allocation favors lead or syndicate positions that provide board seats and operational influence; horizon is multi‑year, value‑creation driven. Underwrites companies by pairing revenue and unit economics momentum with disciplined downside protections. Investment edge derives from hands‑on operating experience, rigorous commercial KPIs and founder/LP alignment.
Focuses on growth‑equity investments in North American middle‑market technology and healthcare companies, prioritizing revenue scaling, repeatable go‑to‑market models and strategic M&A to accelerate exits. Capital allocation favors lead or syndicate positions that provide board seats and operational influence; horizon is multi‑year, value‑creation driven. Underwrites companies by pairing revenue and unit economics momentum with disciplined downside protections. Investment edge derives from hands‑on operating experience, rigorous commercial KPIs and founder/LP alignment.
| Trades 1466 | Longs Won 1061/1466 72% | Profit Factor 8.03 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $411,363.25 |
| Average Win $132,244.41 | Best Trade (Aug 28) $10.89M | Sharpe Ratio -12.74 |
| Average Loss -$43,157.67 | Worst Trade (Sep 01) -$1.13M | Z-Score 10.87 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3w | Expectancy $83,787.49 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,937 | 7,143 | 6,349 | 5,556 | 4,762 | 3,968 | 3,175 | 2,381 | 1,587 | 794 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 59,079 | $11.93M | $18.25M | - | $6.32M | 53.03% | -7.354% |
ABBV AbbVie Inc. | 5,092 | $806,521.58 | $1.28M | - | $471,264.9 | 58.43% | -2.513% |
ABT Abbott Laboratories | 3,572 | $391,838.1 | $377,560.4 | - | -$14,277.7 | -3.64% | +0.085% |
ACN Accenture plc Class A | 23,203 | $2.89M | $3.85M | - | $962,460.76 | 33.33% | +1.611% |
AEE Ameren Corporation | 3,729 | $289,770.09 | $408,735.69 | - | $118,965.6 | 41.06% | +0.791% |
AEP American Electric Power Company, Inc. | 23,546 | $3.22M | $3.01M | - | -$210,975.9 | -6.55% | +0.055% |
AES AES Corporation | 182,294 | $2.05M | $2.68M | - | $629,860 | 30.78% | -1.145% |
AGEM Abrdn Emerging Market Dividend Allocator ETF | 5,054 | $194,003.33 | $240,201.46 | - | $46,198.13 | 23.81% | +0.772% |
AIS VistaShares Artificial Intelligence Supercycle ETF | 4,282 | $365,297 | $272,849.04 | - | -$92,447.96 | -25.31% | +0.473% |
AMAT Applied Materials, Inc. | 1,262 | $249,709.21 | $640,679.55 | - | $390,970.34 | 156.57% | +1.176% |
AMD Advanced Micro Devices, Inc. | 1,128 | $182,918.24 | $537,097.19 | - | $354,178.95 | 193.63% | -1.904% |
AMGN Amgen Inc. | 9,098 | $2.65M | $3.5M | - | $851,363.73 | 32.09% | -0.64% |
AMT American Tower Corporation | 22,744 | $3.72M | $3.94M | - | $222,602.84 | 5.98% | -0.631% |
AMZN Amazon.com Inc | 5,237 | $887,509.91 | $1.42M | - | $534,754.5 | 60.25% | +15.321% |
AVEM Avantis Emerging Markets Equity ETF | 27,844 | $2.04M | $2.49M | - | $453,482.91 | 22.24% | +0.101% |
AVGO Broadcom Inc. | 17,221 | $3.9M | $6.7M | - | $2.8M | 71.9% | +0.371% |
AVUV Avantis U.S. Small Cap Value ETF | 6,172 | $541,440.74 | $773,228.16 | - | $231,787.42 | 42.81% | +0.032% |
BA Boeing Company | 1,151 | $272,719.48 | $248,777.14 | - | -$23,942.34 | -8.78% | -2.155% |
BAC Bank of America Corporation | 83,540 | $3.13M | $5.18M | - | $2.05M | 65.44% | +0.356% |
BBY Best Buy Co., Inc. | 59,759 | $4.53M | $5.15M | - | $620,298.34 | 13.68% | -1.776% |